Mechanical Ventilators and Pulmonary Function Testing Systems
If you are not a subscriber to Meddevicetracker and would like to purchase this report, please send an email to [email protected]. If you would like more information about obtaining a subscription to the Meddevicetracker database and report library, please send an email to [email protected].
Asthma and COPD are the two most prevalent respiratory disorders globally, accounting for a combined 3.7 million deaths annually. Mechanical ventilators generated sales of nearly $740m, with the US accounting for more than 40% of sales.
Market drivers include the rising prevalence of respiratory diseases and conditions, the high prevalence of cigarette smoking, technological advancements leading to expanded applications and a larger potential patient pool, and improving healthcare access in less developed regions. Limiters to this market include a “rebound” effect from the explosive COVID-related demand in 2020 and 2021, the development of alternative device-based and pharmaceutical treatments for COVID-19, and the threat of ongoing COVID-19 restrictions and supply chain issues worldwide.
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for respiratory care products including mechanical ventilators and pulmonary function testing systems. Countries covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2022–27.
Related Medtech Insight articles: